ClinicalTrials.gg
Status unknownNCT03305185Updated Feb 6, 2023

Efficacy of Scoliosis Specific Exercise in Patients With Adolescent Idiopathic Scoliosis During Bracing

An interventional study of Schroth SSE with Bracing and Bracing alone in Adolescent Idiopathic Scoliosis, sponsored by The University of Hong Kong. Status unknown at 1 site in Hong Kong. Open to participants aged 10 Years to 15 Years. Per ClinicalTrials.gov, last updated 2023-02-06.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Randomized
Ages
10 Years to 15 Years
Sex
All
01

Study summary

The purpose of this study is to examine the effectiveness of Schroth scoliosis-specific exercises (SSE) on patients with adolescent idiopathic scoliosis (AIS) during bracing. The goal is to determine if Schroth SSE combined with bracing can is superior in controlling curve progression when compared with bracing alone. Curve progression is defined as worsening of coronal Cobb angle of 6 degrees or more.

Read the detailed description

Adolescent Idiopathic scoliosis (AIS) is a three-dimensional deformity of the spine, characterized by a lateral curvature and vertebral rotation. Its prevalence is estimated to be 2.5% in children between aged 10 and 16 in Hong Kong. Curve progression occurs during pubertal growth spurt. If the primary curve does not exceed 40 degree at skeletal maturity, it is unlikely to continue to progress, and there are little or no long-term clinical consequences. However, if the curve progresses beyond 50 degree during adolescence, it may cause functional limitation, accelerated disc degeneration with potential neurological deficit, cosmetic concerns, decreased quality of life, and possible progression in adulthood. Thus, surgical correction of the deformity with instrumented spinal fusion is usually recommended if the curve reaches 50 degree during adolescence.

Currently, spinal bracing is the only the only non-operative treatment supported with high-quality evidence that can prevent curve progression. In a randomized controlled trial, Weinstein et al. recently reported in the New England Journal of Medicine that bracing was effective in preventing curve progression to threshold for surgery in 72% of cases. The trial was terminated early due to the treatment benefit in favor of bracing. Nonetheless, the authors reported a treatment failure rate of 25% in the randomized cohort, which was similar to previous published studies. Hence, despite the best available non-operative treatment, the number of adolescents ultimately requiring surgery remains substantial. Surgery is associated with medical comorbidities, can cause psychosocial stress to the children and their families, and has significant financial impact on healthcare, with the total costs of spinal surgery to correct AIS ranked second only to appendicitis among children 10 to 17 years of age. Consequently, further effective strategies to prevent scoliosis progression in children are needed.

Scoliosis-specific exercise (SSE) has been proposed as an additional non-operative intervention that may reduce curve progression during the adolescent growth spurt. However, the standard of care for non-operative treatment of AIS varies widely between North America and Europe, and the use of SSE is not universally accepted. SSE is a potentially low-cost intervention that will be of substantial benefit even if a relative risk reduction in curve progression or reaching the threshold for surgery is reduced in a modest proportion of those participating.

SSE, as opposed to generalized physiotherapy, consists of individually-adapted exercises that aim to promote spinal realignment through self-correction and stabilization, as well as modulating patterns of trunk muscles recruitment. Electromyography (EMG) of paraspinal and abdominal muscles in AIS patients revealed disrupted patterns of muscles recruitment, which are associated with a disparity in trunk isometric rotation strength between sides. AIS patients demonstrate proprioceptive and balance control problems, along with a distorted body schema, resulting in a mismatch between the actual spinal alignment and the patients' internal representation of the body. SSE aims to reverse the anomalous patterns of muscle recruitment through training, and modify the body schema with visual and somatosensory feedback. This forms the theoretical neurophysiological basis for using this treatment strategy for AIS.

Schroth SSE is one of the most studied and widely-used schools of SSE. It is a technique tailored to the type of scoliosis and the curve magnitude of each patient. It is based on vertebrae deflections and sagittal corrections that result in horizontal vertebrae de-rotation. It uses rotational breathing and postural auto-correction to reverse the underlying impairments in spinal muscle function, postural control and proprioception which contribute to the development of curvature in AIS. Patients will also be given cognitive behavioral strategies to empower them to self-manage their conditions.

02

Conditions studied

  • Adolescent Idiopathic Scoliosis

Keywords

  • AIS
03

In context

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,286 studies on the registry; 343 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of AIS
  • Male or female from 10 to 15 year-old, inclusive, at the time of consent provided
  • Skeletal immaturity, defined as a Risser grade (amount of ossification and eventual fusion of the iliac apophysis) of 0, 1, or 2
  • Cobb angle of 25-40
  • No prior conservative or surgical treatment for AIS

Exclusion criteria

Exclusion Criteria:

  • An underlying cause or association that may cause scoliosis
  • Leg length discrepancies or lower limb deformities that may interfere with spinal posture
  • Previous spinal surgery
  • Cognitive impairment
  • Those receiving any other forms of treatment including alternative medicine for the treatment of their scoliosis
  • Those who are unable to return for follow-up to complete the trial.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
98 participants (actual)

Study arms

  • Experimental
    Schroth SSE with Bracing

    Patients in this group will be prescribed an outpatient-based Schroth exercise program, as per our preliminary study. It consists of an individualised eight-week outpatient program that includes four initial private training sessions, once every two weeks, where exercises will be taught to the patient and their caregivers. A home exercise program will be instituted thereafter and patients will be required to return for supervised sessions once every two months.

    Combination Product: Schroth SSE with Bracing

  • Active comparator
    Bracing alone

    Patients in the control group will receive standard level of care for bracing, which consists of education on general exercises for spinal movement, strengthening, and balancing. These patients will only attend study assessments with no extra physiotherapy sessions.

    Device: Bracing alone

Interventions

  • Combination productSchroth SSE with Bracing

    Patients in this group will be prescribed an outpatient-based Schroth exercise program, as per our preliminary study. It consists of an individualised eight-week outpatient program that includes four initial private training sessions, once every two weeks, where exercises will be taught to the patient and their caregivers. A home exercise program will be instituted thereafter and patients will be required to return for supervised sessions once every two months.

  • DeviceBracing alone

    Patients in the control group will receive standard level of care for bracing, which consists of education on general exercises for spinal movement, strengthening, and balancing. These patients will only attend study assessments with no extra physiotherapy sessions.

06

What researchers measure

Primary outcomes

  1. Effect of Schroth SSE during bracing versus bracing alone in AIS patients as determined by the difference in coronal Cobb angle pre- and one year post-treatment

    1\. To evaluate the effect of Schroth SSE during bracing versus bracing alone in AIS patients as determined by the difference in coronal Cobb angle pre- and one year post-treatment

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

Secondary outcomes

  1. Compare changes in sagittal plane radiological parameter between Schroth SSE with bracing and bracing alone by EOS Imaging System

    To evaluate the effect of Schroth SSE during bracing compared with bracing alone on sagittal plane radiological parameter using EOS Imaging System

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

  2. Compare changes in transverse plane radiological parameter between Schroth SSE with bracing and bracing alone by EOS Imaging System

    To evaluate the effect of Schroth SSE during bracing compared with bracing alone on transverse plane radiological parameter using EOS Imaging System

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

  3. Compare changes in surface topography between Schroth SSE with bracing and bracing alone using Bunnell's scoliometer

    To evaluate the effect of Schroth SSE during bracing compared with bracing alone on surface topography using Bunnell's scoliometer

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

  4. Compare changes in surface topography between Schroth SSE with bracing and bracing alone using clinical photography

    To evaluate the effect of Schroth SSE during bracing compared with bracing alone on surface topography using clinical photography

    Time frame: baseline, 6 months, 12 months, until skeletal maturity

  5. Compare changes in surface topography between Schroth SSE with bracing and bracing alone using VITUS Smart XXL 3D body scanner system

    To evaluate the effect of Schroth SSE during bracing compared with bracing alone on surface topography using VITUS Smart XXL 3D body scanner system

    Time frame: baseline, 6 months, 12 months, until skeletal maturity

  6. Measure quality of life between Schroth SSE with underarm brace and underarm brace alone by SRS-7 questionaire

    To measure quality of life between Schroth SSE with underarm brace and underarm brace alone by SRS-7 questionaire

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

  7. Measure health outcomes between Schroth SSE with underarm brace and underarm brace alone by EQ-5D-5L

    To measure health outcomes between Schroth SSE with underarm brace and underarm brace alone by EQ-5D-5L

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

  8. Measure patients' perception of their appearance between Schroth SSE with underarm brace and underarm brace alone by Trunk Appearance Perception Scale (TAPS)

    To measure patients' perception of their appearance between Schroth SSE with underarm brace and underarm brace alone by Trunk Appearance Perception Scale (TAPS)

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

  9. Measure levels of pain between Schroth SSE with underarm brace and underarm brace alone by Numeric Pain Ratings

    To measure levels of pain between Schroth SSE with underarm brace and underarm brace alone by Numeric Pain Ratings

    Time frame: baseline, 3 months, 6 months, 12 months, until skeletal maturity

07

Study locations

1 site
  • Duchess of Kent Children's Hospital
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03305185
Responsible party
Dr. Kenny Kwan (Clinical Assistant Professor, The University of Hong Kong) — Principal investigator
First posted
Oct 9, 2017
Start date
Dec 18, 2017
Primary completion
Jun 30, 2023 (estimated)
Completion
Jun 30, 2023 (estimated)
Last update
Feb 6, 2023

Study contacts

Dr Kenny Kwan, BMBCh(Oxon)
principal investigator · The University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion